Related Experiment Video

Updated: Jun 19, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Platelet aggregation in intracranial stents may mimic in-stent restenosis

M Mazighi1, J P Saint Maurice, D Bresson

  • 1Service de Neuroradiologie Diagnostique et Interventionnelle, Hopital Lariboisiere, Paris, France.

AJNR. American Journal of Neuroradiology
|October 17, 2009
PubMed

Insights

Early in-stent restenosis (ISR) occurred due to platelet aggregation, not hyperplasia. Testing revealed clopidogrel inefficiency, resolved by a loading dose, highlighting the need for pre-stent efficacy checks.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • In-stent restenosis (ISR) is a significant complication following percutaneous coronary intervention.
  • Standard antiplatelet therapy aims to prevent thrombotic events and restenosis after stent placement.
  • Assessing the efficacy of antiplatelet agents like clopidogrel is crucial for patient outcomes.

Observation:

  • A case of early ISR was observed despite adherence to a standard antiplatelet regimen.
  • Biologic testing indicated that the patient exhibited clopidogrel inefficiency.
  • Angiography confirmed the disappearance of ISR after administering a clopidogrel loading dose.

Findings:

  • The early ISR was attributed to platelet aggregation, not in-stent myointimal hyperplasia.
  • Ineffective clopidogrel therapy was identified as the underlying cause of the platelet aggregation.
  • Successful management of ISR was achieved by optimizing clopidogrel dosage.

Implications:

  • Verifying clopidogrel efficacy prior to stent implantation is critical.
  • Personalized antiplatelet therapy based on individual response may reduce ISR incidence.
  • This case underscores the importance of pharmacogenetic or biologic testing for antiplatelet drugs.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...